Terminal complement complex C5b-9 and C5b assay in sera of COVID-19 patients with different disease severities
Objective: The aim of this study is to find out the link between the involvement of complement activation in the inflammatory reactions in COVID-19 patients, the deterioration of the clinical status and development of sever COVID-19 in those patients. Methodology: The study included 274 COVID-19 pat...
Main Authors: | Asmaa Nasr El-Din, Kamal Ata |
---|---|
格式: | Article |
語言: | English |
出版: |
Zagazig University, Faculty of Medicine
2022-10-01
|
叢編: | Microbes and Infectious Diseases |
主題: | |
在線閱讀: | https://mid.journals.ekb.eg/article_261883_a3edd5e4a63df2c2e4e6c70bfc4b4951.pdf |
相似書籍
-
Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for Intervention
由: Zvi Fishelson, et al.
出版: (2019-04-01) -
Monoclonal Antibodies Capable of Inhibiting Complement Downstream of C5 in Multiple Species
由: Wioleta M. Zelek, et al.
出版: (2020-12-01) -
Biomarkers of the Complement System Activation (C3a, C5a, sC5b-9) in Serum of Patients before and after Liver Transplantation
由: Marta Budkowska, et al.
出版: (2023-07-01) -
Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation
由: Guo-Qing Tang, et al.
出版: (2023-08-01) -
Complement inhibition by anti-C5 antibodies - from bench to bedside and back again
由: Swiss Medical Weekly
出版: (2007-07-01)